Skip to Main Content

Paper Details

The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer.
Clin Cancer Res
114
2018
Author NameAffiliation
Kristopher K FreseCancer Research UK Manchester Institute, University of Manchester
Zhongwu Lai
Fiona BlackhallInstitute of Cancer Sciences, University of Manchester, and Christie NHS Foundation Trust
  • 1 - 3

Datasets

Release 1.2